Published in Ann Oncol on October 01, 2004
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma. J Clin Oncol (2009) 1.28
Management of relapsed-refractory diffuse large B cell lymphoma. South Asian J Cancer (2014) 0.81
Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement. Korean J Intern Med (2008) 0.78
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure. Bone Marrow Transplant (2009) 0.77
High dose chemotherapy and autologous stem cell transplantation in non-Hodgkin's lymphoma: an eight-year experience. Yonsei Med J (2006) 0.75
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma. Ger Med Sci (2007) 0.75
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia (2011) 4.47
Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol (2001) 4.18
The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol (2001) 3.48
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med (1990) 3.29
Fetoscopic laser ablation of placental anastomoses in twin-twin transfusion syndrome using 'Solomon technique'. Ultrasound Obstet Gynecol (2013) 2.72
Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int (1998) 2.60
Influenza virus matrix protein is the major driving force in virus budding. J Virol (2000) 2.49
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A (1995) 2.33
Temperature monitoring during radiofrequency catheter ablation of accessory pathways. Circulation (1992) 2.31
Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol (2010) 2.14
[Autoimmune hemolytic anemia and myelodysplastic syndromes]. Sangre (Barc) (1989) 2.01
Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation (1992) 2.00
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant (2009) 2.00
Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer (1998) 1.97
Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J Clin Oncol (1993) 1.96
The EBMT activity survey: 1990-2010. Bone Marrow Transplant (2012) 1.96
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene (2006) 1.88
Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1992) 1.88
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol (2005) 1.88
Trapped antihydrogen. Nature (2010) 1.85
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A (1996) 1.84
High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma. Br J Haematol (1999) 1.84
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol (1994) 1.83
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology (2004) 1.77
Alendronate for treatment of renal transplant patients with osteoporosis. Transplant Proc (2003) 1.75
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Persistent adenoviral infection and chronic airway obstruction in children. Am J Respir Crit Care Med (1994) 1.72
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia (2011) 1.70
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer (1992) 1.68
Preliminary clinical experience with a thermal balloon endometrial ablation method to treat menorrhagia. Obstet Gynecol (1994) 1.68
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant (2006) 1.67
Is ilioinguinal/iliohypogastric nerve block always totally safe in children? Paediatr Anaesth (2003) 1.66
Magnetic resonance imaging measurements and clinical changes accompanying transtentorial and foramen magnum brain herniation. Ann Neurol (1993) 1.65
miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ (2010) 1.64
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol (1996) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. Br J Haematol (2003) 1.58
Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol (2005) 1.55
Biventricular pacing using two pacemakers and the triggered VVT mode. Pacing Clin Electrophysiol (2001) 1.55
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant (2006) 1.53
Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A (1998) 1.52
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology. Haematologica (1998) 1.48
Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J Virol (1999) 1.47
Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant (2009) 1.45
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. J Clin Oncol (2001) 1.43
The new Labcor-Santiago pericardial bioprosthesis. J Card Surg (1991) 1.43
Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study. Aliment Pharmacol Ther (2014) 1.43
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplant (1999) 1.41
Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection. Bone Marrow Transplant (1996) 1.41
Seasonal and mood independence of low basal prolactin secretion in premenopausal women with seasonal affective disorder. Am J Psychiatry (1989) 1.40
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia (2004) 1.39
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Intrapontine generation of myokymia in multiple sclerosis. Muscle Nerve (1993) 1.39
[Hematopoietic allogeneic transplantation with attenuated conditioning regimen on an outpatient basis. First experience in Spain]. Med Clin (Barc) (2001) 1.39
Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation. Eur Respir J (1996) 1.38
[Patients with panic disorder: a 5-year follow-up study]. Acta Psiquiatr Psicol Am Lat (1992) 1.37
Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol (1998) 1.37
Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37
[Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients]. Med Clin (Barc) (1997) 1.36
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood (1994) 1.36
Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis (1998) 1.34
Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant (2013) 1.34
Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth (2006) 1.33
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions (1993) 1.32
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification. J Pathol (2008) 1.32
The relationship between glycogen synthesis, biofilm formation and virulence in salmonella enteritidis. FEMS Microbiol Lett (2000) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Resonant quantum transitions in trapped antihydrogen atoms. Nature (2012) 1.32
Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 1.31
Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica (2001) 1.30
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome. Leukemia (2009) 1.29
Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant (2004) 1.29